Table 1.
Demographic characteristics of trial participants
|
Plasmodium falciparum |
Plasmodium vivax |
||||
|---|---|---|---|---|---|
| Cohort 1a (n=13) | Cohort 2a (n=11) | Cohort 1b (n=5) | Cohort 2b (n=9) | Cohort 3b (n=7) | |
| Age, years | |||||
| Mean (SD) | 36·2 (12·1) | 43·9 (17·25) | 35·0 (4·90) | 41·9 (15·1) | 38·3 (15·2) |
| Median (IQR) | 33 (28–44) | 48 (29–59) | 33 (32–38) | 47 (32–54) | 39 (26–43) |
| Range | 20–58 | 18–67 | 30–42 | 18–59 | 21–67 |
| Sex | |||||
| Male | 10 (77%) | 8 (73%) | 3 (60%) | 5 (56%) | 4 (57%) |
| Female | 3 (23%) | 3 (27%) | 2 (40%) | 4 (44%) | 3 (43%) |
| Weight, kg | |||||
| Mean (SD) | 60·55 (10·45) | 62·76 (8·28) | 54·30 (6·77) | 60·70 (10·55) | 63·49 (10·56) |
| Median (IQR) | 62·6 (54–67) | 62·2 (59–68) | 53·5 (51–54) | 61·5 (52–70) | 67·4 (54–72) |
| Range | 46–80 | 50–78 | 48–66 | 46–75 | 48–77 |
| Body-mass index, kg/m2 | |||||
| Mean (SD) | 24·6 (3·6) | 25·4 (3·3) | 22·9 (1·2) | 25·7 (3·5) | 26·3 (3·5) |
| Median (IQR) | 24·3 (22–27) | 26·3 (22–29) | 22·9 (22·8–22·9) | 26·3 (23–28) | 26·7 (22–29) |
| Range | 20·1–32·7 | 21·1–29·8 | 21·1–24·6 | 20·0–30·4 | 21·9–31·6 |
Data are n (%), unless otherwise specified. All patients were mixed race, of Hispanic or Latino ethinicity.